Mirahype S 50/5 Tablet ER
Images are for reference. Actual packaging may vary.
1 units • OtherPrescription requiredSchedule H
Mirahype S 50/5 Tablet ER
Mirabegron (50mg) + Solifenacin (5mg)
₹495.00
1 units • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Mirabegron 50 mg
+1 more active ingredient
How It Works
Solifenacin antagonizes muscarinic receptors in the bladder, reducing detrusor muscle contractions and increasing bladder capacity.
Medicine Strength
50 mg
All Active Ingredients
Mirabegron50 mg
Solifenacin5 mg
Uses & Benefits
Medical applications
Mirahype S 50/5 Tablet ER is a once-daily, extended-release formulation containing mirabegron (50mg) and solifenacin (5mg), a combination therapy for the treatment of overactive bladder (OAB) with symptoms of urinary frequency, urgency, and incontinence. This product is designed to provide sustained release of its active ingredients, mirabegron and solifenacin, over an extended period, allowing for consistent and reliable therapeutic effects.
Read full descriptionShow less
Mirabegron, a β3-adrenoceptor agonist, increases urinary bladder capacity and reduces urgency, while solifenacin, a muscarinic receptor antagonist, reduces the frequency of bladder contractions and urinary incontinence episodes. The combination of these two compounds synergistically works together to provide enhanced relief from OAB symptoms. Mirahype S 50/5 Tablet ER is indicated for patients who have not responded adequately to previous therapy or who have intolerable side effects.
This product is contraindicated in patients with known hypersensitivity to either mirabegron or solifenacin, and caution should be exercised in patients with moderate to severe renal impairment.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Information regarding the use of Mirahype S 50/5 Tablet ER during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Mirahype S 50/5 Tablet ER during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
There is limited information available on the use of Mirahype S 50/5 Tablet ER in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Mirahype S 50/5 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Mirahype S 50/5 Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Mirahype S 50/5 Tablet ER
